Table 2.
Potential risk factors identified by univariate and multivariate logistic regression analyses.
| Characteristics | Univariable | Multivariable | ||||
|---|---|---|---|---|---|---|
| OR | CI | p-value | OR | CI | p-value | |
| WBC (1012/L) | 1.418 | 1.115-1.804 | 0.004 | 1.302 | 0.749-2.263 | 0.349 |
| RBC (109/L) | 0.687 | 0.402-1.174 | 0.170 | |||
| Hb (g/L) | 0.989 | 0.972-1.007 | 0.240 | |||
| PIT (109/L) | 1.004 | 0.998-1.009 | 0.173 | |||
| K (mmol/L) | 1.226 | 0.658-2.285 | 0.521 | |||
| Ca (mmol/L) | 0.996 | 0.955-1.039 | 0.858 | |||
| BUN (mmol/L) | 4.027 | 1.865-8.694 | <0.001 | |||
| Scr (μmol/L) | 5.389 | 0-2.418E+30 | 0.961 | |||
| UA (μmol/L) | 1.007 | 1.003-1.010 | <0.001 | |||
| GLU (mmol/L) | 1.117 | 0.750-1.664 | 0.586 | |||
| TC (mmol/L) | 1.296 | 0.914-1.837 | 0.145 | |||
| TG (mmol/L) | 2.274 | 1.097-4.714 | 0.027 | 1.148 | 0.261-5.042 | 0.855 |
| ALB (g/L) | 0.918 | 0.847-0.993 | 0.034 | 0.885 | 0.707-1.108 | 0.286 |
| β2-MG (mg/L) | 1.576 | 1.287-1.932 | <0.001 | 1.921 | 1.200-3.075 | 0.007 |
| LDH (U/L) | 1.003 | 1.000-1.006 | 0.048 | 1.002 | 0.994-1.009 | 0.652 |
| eGFR (ml/min/1.73m2) | 0.776 | 0.652-0.925 | 0.004 | |||
| CRP (mg/L) | 1.008 | 0.991-1.025 | 0.377 | |||
| ESR (mm/h) | 1.000 | 0.998-1.013 | 0.993 | |||
| M protein(g/L) | 0.985 | 0.930-1.043 | 0.597 | |||
| free κ light chain (mg/L) | 1.000 | 0.999-1.000 | 0.714 | |||
| free λ light chain (mg/L) | 1.000 | 1.000-1.000 | 0.031 | 1.000 | 1.000-1.000 | 0.985 |
| κ/λ | 1.006 | 0.990-1.023 | 0.441 | |||
| κ-λ (mg/L) | 1.000 | 1.000-1.000 | 0.019 | |||
RBC, red blood cell; PLT, platelet; K, serum potassium; BUN, serum urea nitrogen; GLU, fasting blood glucose; TC, total cholesterol; eGFR, estimated glomerular filtration rate; CPR, C-reactive protein; ESR, erythrocyte sedimentation rate; free κ light chain, serum dissociation κ light chain; κ/λ, serum dissociation κ light chain and λ light chain ratio.